These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34811632)

  • 21. CCN6: a novel method of aTAKing cancer.
    Leask A
    J Cell Commun Signal; 2013 Jun; 7(2):161-2. PubMed ID: 23292930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of CCN6 overexpression on the cell motility and activation of p38/bone morphogenetic protein signaling pathways in pancreatic cancer cells.
    Nam MW; Lee HK; Kim CW; Choi Y; Ahn D; Go RE; Choi KC
    Biomed Pharmacother; 2023 Jul; 163():114780. PubMed ID: 37105075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selenoproteins reduce susceptibility to DMBA-induced mammary carcinogenesis.
    Hudson TS; Carlson BA; Hoeneroff MJ; Young HA; Sordillo L; Muller WJ; Hatfield DL; Green JE
    Carcinogenesis; 2012 Jun; 33(6):1225-30. PubMed ID: 22436612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. On how CCN6 suppresses breast cancer growth and invasion.
    Huang W; Pal A; Kleer CG
    J Cell Commun Signal; 2012 Mar; 6(1):5-10. PubMed ID: 21842227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metaplastic Carcinoma of the Breast Is More Aggressive Than Triple-negative Breast Cancer: A Study From a Single Institution and Review of Literature.
    El Zein D; Hughes M; Kumar S; Peng X; Oyasiji T; Jabbour H; Khoury T
    Clin Breast Cancer; 2017 Aug; 17(5):382-391. PubMed ID: 28529029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination of PI3K and MEK inhibitors yields durable remission in PDX models of PIK3CA-mutated metaplastic breast cancers.
    Coussy F; El Botty R; Lavigne M; Gu C; Fuhrmann L; Briaux A; de Koning L; Dahmani A; Montaudon E; Morisset L; Huguet L; Sourd L; Painsec P; Chateau-Joubert S; Larcher T; Vacher S; Melaabi S; Salomon AV; Marangoni E; Bieche I
    J Hematol Oncol; 2020 Feb; 13(1):13. PubMed ID: 32087759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ccn6 Is Required for Mitochondrial Integrity and Skeletal Muscle Function in Zebrafish.
    Sengupta A; Padhan DK; Ganguly A; Sen M
    Front Cell Dev Biol; 2021; 9():627409. PubMed ID: 33644064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CCN6 regulates mitochondrial respiratory complex assembly and activity.
    Padhan DK; Sengupta A; Patra M; Ganguly A; Mahata SK; Sen M
    FASEB J; 2020 Sep; 34(9):12163-12176. PubMed ID: 32686858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.
    Cicchini M; Chakrabarti R; Kongara S; Price S; Nahar R; Lozy F; Zhong H; Vazquez A; Kang Y; Karantza V
    Autophagy; 2014; 10(11):2036-52. PubMed ID: 25483966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epithelial Mesenchymal Transition and Immune Response in Metaplastic Breast Carcinoma.
    González-Martínez S; Pérez-Mies B; Pizarro D; Caniego-Casas T; Cortés J; Palacios J
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive profiling of metaplastic breast carcinomas reveals frequent overexpression of programmed death-ligand 1.
    Joneja U; Vranic S; Swensen J; Feldman R; Chen W; Kimbrough J; Xiao N; Reddy S; Palazzo J; Gatalica Z
    J Clin Pathol; 2017 Mar; 70(3):255-259. PubMed ID: 27531819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer.
    Wang S; Liu JC; Kim D; Datti A; Zacksenhaus E
    Breast Cancer Res; 2016 Jan; 18(1):9. PubMed ID: 26781438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transferrin Coated d-penicillamine-Au-Cu Nanocluster PLGA Nanocomposite Reverses Hypoxia-Induced EMT and MDR of Triple-Negative Breast Cancers.
    Shome R; Ghosh SS
    ACS Appl Bio Mater; 2021 Jun; 4(6):5033-5048. PubMed ID: 35007052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The emerging role of CCN6 in breast cancer invasion.
    Lorenzatti G; Huang W; Kleer CG
    Cellscience; 2009 Oct; 6(2):146-157. PubMed ID: 29071006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined deletion of Pten and p53 in mammary epithelium accelerates triple-negative breast cancer with dependency on eEF2K.
    Liu JC; Voisin V; Wang S; Wang DY; Jones RA; Datti A; Uehling D; Al-awar R; Egan SE; Bader GD; Tsao M; Mak TW; Zacksenhaus E
    EMBO Mol Med; 2014 Dec; 6(12):1542-60. PubMed ID: 25330770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk.
    Matise LA; Palmer TD; Ashby WJ; Nashabi A; Chytil A; Aakre M; Pickup MW; Gorska AE; Zijlstra A; Moses HL
    Breast Cancer Res; 2012 Jul; 14(4):R98. PubMed ID: 22748014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. WISP-3/CCN6 inhibits apoptosis by regulating caspase pathway after hyperoxia in lung epithelial cells.
    Wei S; Wang K; Zhao Z; Huang X; Tang W; Zhao Z
    Gene; 2018 Oct; 673():82-87. PubMed ID: 29920361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. APC selectively mediates response to chemotherapeutic agents in breast cancer.
    VanKlompenberg MK; Bedalov CO; Soto KF; Prosperi JR
    BMC Cancer; 2015 Jun; 15():457. PubMed ID: 26049416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transforming growth factor-beta regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment.
    Bierie B; Stover DG; Abel TW; Chytil A; Gorska AE; Aakre M; Forrester E; Yang L; Wagner KU; Moses HL
    Cancer Res; 2008 Mar; 68(6):1809-19. PubMed ID: 18339861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin-like growth factor receptor signaling in breast tumor epithelium protects cells from endoplasmic reticulum stress and regulates the tumor microenvironment.
    Obr AE; Kumar S; Chang YJ; Bulatowicz JJ; Barnes BJ; Birge RB; Lazzarino DA; Gallagher E; LeRoith D; Wood TL
    Breast Cancer Res; 2018 Nov; 20(1):138. PubMed ID: 30458886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.